Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome

Human Reproduction

Volumn 23, Issue 1, 2008, Pages 153-159

  Cascella, Teresa ^a   Palomba, Stefano ^b   De Sio, Ilario ^c   Manguso, Francesco ^a   Giallauria, Francesco ^d   De Simone, Biagio ^a   Tafuri, Domenico ^e   Lombardi, Gaetano ^a   Colao, Annamaria ^a   Orio, Francesco ^a,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Cardiac Rehabilitation Unit   (Italy)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Cardiovascular risk; Hyperandrogenism; Insulin resistance; PCOS; Visceral fat

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR; INSULIN;

ABDOMINAL FAT; ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTERIAL WALL THICKENING; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPENDENT VARIABLE; DISEASE ASSOCIATION; DISEASE MARKER; ECHOGRAPHY; FEMALE; HUMAN; HYPERANDROGENISM; INDEPENDENT VARIABLE; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEUKOCYTE COUNT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; WAIST CIRCUMFERENCE; BLOOD; BLOOD FLOW; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; COMMON CAROTID ARTERY; CROSS-SECTIONAL STUDY; HOMEOSTASIS; INTIMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL; TUNICA MEDIA; VASODILATATION;

ADULT; ANTHROPOMETRY; AREA UNDER CURVE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LINEAR MODELS; POLYCYSTIC OVARY SYNDROME; REGIONAL BLOOD FLOW; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 40549136010     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem356     Document Type: Article

References (46)

1. Abe T, Kawakami Y, Sugita M, Yoshikawa K, Fukunaga T. Use of B-mode ultrasound for visceral fat mass evaluation: comparison with magnetic resonance imaging. Appl Human Sci 1995;14:133-139.
2. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-1935.
3. Armellini F, Zamboni M, Rigo L, Bergamo-Andreis IA, Robbi R, Marchi M, Borsello O. Sonography detection of small intra-abdominal fat variations. Int J Obesity 1991;15:847-852.
4. Barbieri RL. Infertility. In: Yen SSC, Yaffe RB, Barbieri RL (eds). Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. Philadelphia, WB Saunders, 1999,562-593.
5. Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, Muller MJ. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obesity 2006;30:475- 483.
6. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006;119:e1-e6.
7. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, Di Fede G, Rini G. Abdominal fat quantity and distribution in women with polycystic ovary sindrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007;92:2500-2505.
8. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996;16:368-374.
9. Corretti MC, Andreson TJ, Benjamin EJ, Celemajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265.
10. Cussons AJ, Stuckey BGA, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 2006;185:227-239.
11. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005;149:54-60.
12. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-1236.
13. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 1999;23:1108-1112.
14. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obesity 2002;26:883-896.
15. Gasteyger C, Tremblay A. Metabolic impact of body fat distribution. J Endocrinol Invest 2002;25:876-883.
16. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-2698.
17. Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, Yoshizumi M, Toba K, Ouchi Y. The impairment of flow-mediated vasodilation in obese men with visceral accumulation. Int J Obes Relat Metab Disord 1998;22:477-484.
18. Hirooka M, Kumagi T, Kurose K, Nakanishi S, Michitaka K, Matsuura B, Horiike N, Onji M. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med 2005;44:794-799.
19. Iacobellis G. Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Curr Drug Targets Cardiovasc Haematol Disord 2005;5:345-353.
20. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-688.
21. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004;79:379-384.
22. Kawamoto R, Kajiwara T, Oka Y, Takagi Y. Association between abdominal wall fat index and carotid atherosclerosis in women. J Atheroscler Thromb 2002;9:213-218.
23. Kim SK, Kim UJ, Hur KY, Choi SH, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Visceral fat thickness measured by US can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr 2004;79:593-599.
24. Lakhani K, Leonard A, Seifalian AM, Hardiman P. Microvascular dysfunction in women with polycystic ovary syndrome. Hum Reprod 2005;20:3219- 3224.
25. Legro RS, Finegood D, Dunaif A. A fasting glucose-to-insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-2698.
26. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JCN. Sonographic measurements of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obesity 2003;27:1267-1273.
27. Liu KH, Chan YL, Chan JC, Chan WB. Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis 2005;179:299-304.
28. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG 2006;113:817-824.
29. Orio F, Palomba S, Spinelli L, Cascella T, Tauchmanova L, Zullo F, Lombardi G, Colao A. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical prospective case-control study. J Clin Endocrinol Metab 2004a;89:3696-3701.
30. Orio F Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo R, Labella D, Zullo F, Lombardi G, Colao A. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004b;89:4588-4593.
31. Orio F Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova L, Nardo LG, Labella D, Savastano S, Russo T et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:2-5.
32. Orio F, Palomba S, Colao A. Cardiovascular risk in women with polycystic ovary syndrome. Fertil Steril 2006;86:S20-S21.
33. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002;77:1095-1105.
34. Palomba S, Zupi E, Russo T, Oppedisano R, Manguso F, Falbo A, Tolino A, Mattei A, Mastrantonio P, Zullo F. Pre-surgical assessment of intra-abdominal visceral fat in obese patients with early stage endometrial cancer treated with laparoscopic approach: relationships with earl laparotomic conversions. J Minim Invasive Gynecol 2007;14:195-201.
35. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005;183:308-315.
36. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Stepard MK, Baron AD. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410-1415.
37. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Muller B. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 2005;90:6014-6021.
38. Ribeiro-Filho FF, Faria AN, Kohlmann O, Ajzen S, Ribiero AB, Zanella MT, Ferreira RG. Ultrasonography for the evaluation of visceral fat and cardiovascular risk. Hypertension 2001;38:713-717.
39. Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002;282:E657-E663.
40. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19:41-47.
41. Sowers JR. Obesity and cardiovascular disease. Clin Chem 1998;44:1821-1825.
42. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y, Murayama H, Oshima H, Shinomiya M, Shirai K. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 1993;95:309-314.
43. Tai MM. A mathematic model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994;17:152-154.
44. Tiras MB, Yalcin R, Noyan V, Maral I, Yildirim M, Dortlemez O, Daya S. Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 1999;14:1949-1952.
45. Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 2005;20:2409- 2413.
46. Yildrim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary sindrome. Fertil Steril 2003;79:1358-1364.